Infection control and the significance of sputum and other respiratory secretions from adult patients with cystic fibrosis

被引:5
作者
Moore J.E. [1 ,2 ]
Shaw A. [1 ]
Howard J.L. [3 ]
Dooley J.S.G. [2 ]
Elborn J.S. [3 ,4 ]
机构
[1] Northern Ireland Public Health Lab., Department of Bacteriology, Belfast City Hospital, Belfast BT9 7AD, Lisburn Road
[2] School of Biomedical Sciences, University of Ulster, Coleraine Co. Londonderry BT52 1SA, Cromore Road
[3] N. IRL Reg. Adult Cyst. Fibros. Ctr., Belfast City Hospital, Belfast BT9 7AB, Lisburn Road
[4] Department of Respiratory Medicine, The Queen's University of Belfast, Belfast City Hospital, Belfast BT9 7AB, Lisburn Road
关键词
Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Burkholderia Cepacia; Stenotrophomonas Maltophilia; Respiratory Secretion;
D O I
10.1186/1476-0711-3-8
中图分类号
学科分类号
摘要
Background: There is limited data available on the environmental and public health impact of the microbiological hazards associated with sputa from patients with cystic fibrosis [CF]. Pseudomonas aeruginosa, Burkholderia cenocepacia (formerly Burkholderia cepacia genomovar III), Staphylococcus aureus and Stenotrophomonas maltophilia are bacterial pathogens which are commonly found in the sputum of CF patients. A study was performed to ascertain the amount of sputum produced relating to microbial loading, as well as the diversity of bacteria present in a population of adult patients, with particular attention to pathogenic organisms. Methods: Sputum from adult [>18 years old] CF patients [n = 20], chosen randomly from a population of 138 CF patients, was collected over a 24 h period on admission to the in-patient CF unit and enumerated quantitatively, as well as the sputa from 138 adult CF patients was examined qualitatively for the presence of infecting microflora. In addition, all different phenotypes from the sputum of each patient were identified phenotypically employing a combination of conventional identification methods [e.g. oxidase], as well as the API Identification schemes [API 20 NE, API 20 E]. Results: This study demonstrated that patients with cystic fibrosis generate large numbers of bacteria in their sputum, approximating to 109 organisms per patient per day. Although these organisms are introduced to the environment from the respiratory tract mainly via sputum, relatively few represent true bacterial pathogens and therefore are not clinically important to the general public who are immunocompotent. The greatest risk of such environmental microbial loading is to other patients with CF and therefore CF patients should be made aware of the hazards of acquiring such organisms from the environment, as well as socializing with other CF patients with certain transmissible types, such as Pseudomonas aeruginosa and Burkholderia cenocepacia. Conclusions: Environmental health professionals should therefore be aware that CF patients are a greater risk to their peer grouping rather than to the general public or health care workers and that good personal hygiene practices with CF patients should be encouraged to minimize environmental contamination and potential acquistion. © 2004 Moore et al; licensee BioMed Central Ltd.
引用
收藏
页数:5
相关论文
共 14 条
[1]  
Anon A., About cystic fibrosis
[2]  
What is CF?, (2003)
[3]  
Lyczak J.B., Cannon C.L., Pier G.B., Lung infections associated with cystic fibrosis, Clin. Microbiol. Rev., 15, pp. 194-222, (2002)
[4]  
Rajan S., Saiman L., Pulmonary infections in patients with cystic fibrosis, Sem. Respir. Infect., 17, pp. 47-56, (2002)
[5]  
Hamutcu R., Francis J., Karakoc F., Bush A., Objective monitoring of cough in children with cystic fibrosis, Ped. Pulmonol., 34, pp. 331-335, (2002)
[6]  
Wong K., Roberts M.C., Owens L., Fife M., Smith A.L., Selective media for the quantitation of bacteria in cystic fibrosis sputum, J. Med. Microbiol., 17, pp. 113-119, (1984)
[7]  
Maduri-Traczewski M., L'Heureux C., Escalona L., Macone A., Goldmann D., Facilitated detection of antibiotic-resistant Pseudomonas in cystic fibrosis sputum using homogenized specimens and antibiotic-containing media, Diagn. Microbiol. Infect. Dis., 5, pp. 299-305, (1986)
[8]  
Burns J.L., Emerson J., Stapp J.R., Yim D.L., Krzewinski J., Louden A., Ramsey B.W., Clausen C.R., Microbiology of sputum from patients at cystic fibrosis centers in the United States, Clin. Infect. Dis., 27, pp. 158-163, (1998)
[9]  
Burns J.L., Van Dalfsen J.M., Shawar R.M., Otto K.L., Garber R.L., Quan J.M., Montgomery A.B., Albers G.M., Ramsey B.E., Smith A.L., Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis, J. Infect. Dis., 179, pp. 1190-1196, (1999)
[10]  
Bauernfeind A., Bertele R.M., Harms K., Horl G., Jungwirth R., Petermuller C., Przyklenk B., Weisslein-Pfister C., Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis, Infect, 15, pp. 270-277, (1987)